Sodium Acetate
Active substance: sodium acetate
INJECTION · SODIUM ACETATE ANHYDROUS 164 mg/mL
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM ACETATE ANHYDROUS · 164 mg/mL
Registration
- Registration number
- 0641-6262
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0641-6262 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0641-6262 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0641-6262 · Verified 2026-10-09 · open in source